chrisvoncsefalvay/vaers-outcomes huggingface dataset:
CURRENTLY ADMITTED.  The patient is a 64 y.o. male with past medical history significant for obesity, RLS, OSA, type 2 diabetes, HDL, depression, anxiety, PTSD who presented emergency department complaints of shortness of breath.  Per patient, everyone at his home currently is COVID positive.  He notes that he began having symptoms 4 days ago.  States he has been having shortness of breath, minor nonproductive cough, intermittent fever/chills, decreased appetite, generalized weakness/fatigue, nasal congestion and sore throat.  Does have some minor lightheadedness/dizziness but notes that is chronic in nature.  Denies any abdominal pain, nausea/vomiting, diarrhea.  Does note decreased urine output but notes he has not been taking in any fluids.  Patient is vaccinated but not yet boosted.  Notes he has been mostly compliant with his medications but has missed a few doses since symptoms started.   Upon arrival to emergency department, patient was tachycardic, tachypneic and hypoxic.  Baseline blood work was obtained which was remarkable for elevated bilirubin of 2.4 but otherwise grossly unremarkable.  COVID PCR positive. CT thorax was obtained was negative for PE but did show bilateral patchy airspace disease and hepatic steatosis.  Patient was stabilized on 10 L via NRB.  Patient was given a 500 mL bolus for hydration and started on Decadron.  Patient was then transferred to another Hospital admitted to General Medicine for further evaluation and management.
Narrative: COVID infection following COVID vaccine series 04/13, Moderna dose #1 05/10, Moderna, dose #2 09/14 pt cc: cough, fatigue, loss of taste or smell, myalgias, dyspnea, headache, nausea, fever exposure: unknown 09/15 COVID swab, result: detected 09/15 SARS-COV-2 Variant Sequencing result: pending 09/24 clinically resolved
all of the vaccinated I know ALL are getting covid-19; all of the vaccinated I know ALL are getting covid-19; This is a spontaneous report from a contactable consumer or other non hcp.  A female patient of an unspecified age received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection (Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was Reported that, The patient experienced all of the vaccinated know all are getting covid-19 on an unspecified date with outcome of unknown. The patient underwent lab tests and procedures which included sars-cov-2 test positive on now what about all of the vaccinated I know ALL are getting covid-19. The outcome of event was Unknown   The lot number for [BNT162B2], was not provided and will be requested during follow up. Linked Report(s): US-PFIZER INC-202101281144 same reporter, different patient.
Dizziness, mental disorientation, loss of balance, falls, muscle weakness (arms and legs) had to use hand rails up and down stairs, progressing for 2 months, slowly recovery over next 2+ months, short stumbling steps.
This is an instance of breakthrough COVID-19 after which death occurred.   The individual was vaccinated with the Pfizer product on 02/06/2021 and 02/27/2021. There is a third dose in the state immunization system, but it has an administered date of 04/06/2022 which is after this person's death so it is likely this is an error.   The individual tested positive for COVID-19 on 10/06/2021 at an out-of-state hospital. They had been hospitalized from 10/04/2021 to 10/19/2021. They were then re-admitted on 10/22/2021. They experienced complications of COVID-19 pneumonia, acute kidney injury, multiple organ failure, sepsis, and cellulitis. They were placed on comfort cares and died on 10/28/2021. Specific state issued the death certificate.
could not lift arm as high as usual; arm felt weak; Red mark on the back of the arm where received the Injection; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPOKINESIA (could not lift arm as high as usual), MUSCULAR WEAKNESS (arm felt weak) and VACCINATION SITE ERYTHEMA (Red mark on the back of the arm where received the Injection) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOKINESIA (could not lift arm as high as usual), MUSCULAR WEAKNESS (arm felt weak) and VACCINATION SITE ERYTHEMA (Red mark on the back of the arm where received the Injection). At the time of the report, HYPOKINESIA (could not lift arm as high as usual), MUSCULAR WEAKNESS (arm felt weak) and VACCINATION SITE ERYTHEMA (Red mark on the back of the arm where received the Injection) outcome was unknown.            No relevant concomitant medications were provided. No treatment information was provided. The action taken for mRNA-1273 was not applicable.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 16Mar2021 at 14:00 as dose 1, single (Lot number: EP7534), in left arm, on 12Apr2021 as dose 2, single (Lot number: EW0153), in left arm and on 22Nov2021 at 14:00 as dose 3 (booster), single (Lot number: FH8028) at the age of 64 years, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative, notes: After testing negative; positive, notes: Experienced rebound Covid 7 days. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: Patient had not received other medication in 2 weeks. Anti viral details reported to be COVID 19 Treatment, brand name was Paxlovid, treatment was started on 18Jul2022 and was stopped on 22Jul2022, lot number 1910754A, indication included Treatment of COVID-19. Patient had no known allergies.  No follow-up attempts are possible. No further information is expected.
Sinus Infection with extremely dry nose. I was given augmentin  on 10 -22-22 and presidone on 10-28-22. I am not sure this is an adverse effect due to me having sinus issues but I have never had an extremely dry nose.
2 days of chills, weakness, profound fatigue & of course sore arm, starting about 4-5 hours after the shot and lasting for ~ 48 hours
Patient was hospitalized a day after dose was given. Not sure on exact condition. Patient came to pharmacy to get extra dose due to immunocompromised health status. Pfizer was the original shot she received, but was not available at the pharmacy so she was given moderna per cdc guideline
We left the doctors office and I brought patient back to school. He went to the lunch room and by then the site of the vaccine for Chicken Pox was swollen and hot, with a 4 inch diameter cicle of red around it. I went home (10 Minutes), got some ibprofen 150mg and had patient take that. I had asked the nurse if I should give him ibprofen becasue that is what I have been told in the past and she said no. So I didn't give it to him then. In about an hour the swelling and redness was dissapearing. When I pick him up at daycare he was coughing and his nose was stuffy and clear liquid. Tuesday morning he didn't feel well and was still coughing. Wendesday night he coughed all night and look and felt awful. I took him to the doctors Wednesday Sept 14th. She said he was having a reaction to the shot. Last night he didn't cough all night, just a little. Today, Sept 15, he seems to be feeling ok, and the cough and stuffy nose is going away. I was told to report this reaction to you by my doctor.
Information has been received from a claims administer, concerning a female who on 30-APR-2013, was vaccinated with a dose of ZOSTAVAX (Merck) (dose, route and lot# not reported). The patient experienced an adverse reaction to ZOSTAVAX (Merck). It was unknown if the patient sought medical attention. At the time of reporting, the outcome was unknown. Additional information is not expected.
This spontaneous report as received from a medical assistant refers to multiple unspecified patients who on unspecified dates were administered with PEDVAXHIB (dose, frequency and indication not reported) that went through a supported temperature excursion. No adverse effects reported. This is one of several reports received from same source. Additional information is not expected.
Administration complication- Mother of child's hand was near the patient's thigh and the needle grazed the mother of child's finger. I stopped, capped the needle, and applied gauze and a bandaid since the needle broke skin. None of the vaccine was released at any time of the grazing. I told the mother that I would need to change the needle before administering the vaccine since it grazed her.  I left the room and returned with the new needle. I changed the needle and discarded the original in the sharps container. I communicated to keep hands further away and positioned the thigh with more room then continued to administer without complication.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 08Apr2021 as dose 1, single (Lot number: EW0151), in right arm, on 29Apr2021 as dose 2, single (Lot number: EW0175), in left arm and on 11Nov2021 as dose 3 (booster), single (Lot number: FG3527) at the age of 38 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: sulfa" (unspecified if ongoing); "Known allergies: Wheat" (unspecified if ongoing); "Psoriatic arthritis" (unspecified if ongoing); "migraines" (unspecified if ongoing); "asthma" (unspecified if ongoing); "allergies" (unspecified if ongoing); "endometriosis" (unspecified if ongoing); "interstitial cystitis" (unspecified if ongoing); "chronic pain" (unspecified if ongoing); "fibromyalgia" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Known allergies: yes-amoxicillin, reaction(s): "Known allergies: Yes-Amoxicillin"; Known allergies: macrodantin, reaction(s): "Known allergies: macrodantin"; Known allergies: prochlorperazine, reaction(s): "Known allergies: prochlorperazine"; Known allergies: pyridium, reaction(s): "Known allergies: pyridium". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course was reported as, patient experienced a rebound case of COVID after completing the treatment of Paxlovid on 25Jun2022. Patient was treated with prednisone. She was not recovered from symptoms.
Four hours after injection,  patient developed severe diarrhea (green) which continued for 11 days.  Patient did have an ER trip and two visits to her pcp.  Multiple tests were run including stool samples.   Sed rate was 36, stool samples negative, wbc 10, cr cl 1.44, gfr 48, rdw 17%, co2 19, albumen 1, alkaline phos 105, aft 13, bun 28, chlor 112, lymphcytes 23.8 pt prescribed dicyclomine which inreased bowel transit time.  pt states that she is still dehyrated and very tired, stoll normal at this time.
Sympyoms- hot/flushing, nausea, slurred speech, inability to move startes about 30 mins after receiving vaccine. Patient went to hospital and was kept there for about 3 hours severe symptoms lasted about 2 days. Patient still has side effects- headache, fever, nausea today
unapproved diluent used; unapproved diluent used; This case was reported by a other health professional via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 16-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA5928, expiry date 21st August 2022) for prophylaxis.   On 29th June 2022, the patient received Menveo. On 29th June 2022, unknown after receiving Menveo, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.  Additional Information: GSK Receipt Date: 07-Jul-2022 Reporter's Comments: The reporter was medical assistant. The patient received a Menveo vaccine that was reconstituted by using an unapproved diluent. The reporter consented to follow up via email. Additional Supportive Information: The patient received a Menveo vaccine that was reconstituted by using an unapproved diluent, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered.
A lot of head issues with first vaccine, tenderness, sharp pain in calf muscle went around leg and then down to foot and back up leg. Little spots of pain in leg.
Patient presented and advised clinic staff that she has had two previous anaphylatic reactions to medications (calcipotriene and lidocaine) including swelling of the tongue, angioedema and SOB).  Patient received COVID 19 vaccine and was being monitored for 30 min duration.  Ten minutes into the monitoring period the patient developed pruritus starting with her hands and then developed to a generalized pruritus.  Patient was checked into the ED, given Benadryl IM and was monitored.  Released after about 3 hrs of observation.
Got sick every year/ still get sick once a year; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a adult patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, less than a year after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   It was unknown if the reporter considered the sickness to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as per the patient designation. The patient got flu shot every year in the military.  The patient got sick every year, stopped taking them when the patient retired, still the patient get sick once a year. The patient reported that may be the shot didn't give him or her the flu, but it sure as hell didn't keep the patient from getting sick.
Patient experienced localized swelling and hematoma following the injection. She reported no pain, no swelling of the lips or tongue, no difficulty breathing or swallowing upon initial evaluation by dr. She was given an ice pack to help address the swelling and she was asked to stay 30 minutes for observation. When she departed the clinic she reported feeling fine.
I had pain in my left arm, hand, and wrist that kept me awake at night.  I also felt pain in my joints and was fatigued and ran a very low grade fever.
Approx 5 hours after receiving the flu shot I developed a large swollen area only left deltoid area.  The swelling continued to worsen and progressed to what was diagnosed as a flare up of my autoimmune disease.
12yo pt received Pfizer Pedi Vaccine.  Pt stable, discussed w/ mother.  Per agency guidelines, additional dose not administered.  Advised mother that son will receive adult dose Pfizer upon return for 2nd dose. Pt stable and released from the vaccination site.
Pt reported roof of mouth itchy, body itching, ears ringing and felt fullness/clogged, headache.  Benadryl 50 mg PO provided with additional monitoring and resolved.
One day after vaccination: Muscle aches entire body.  Second day after vaccination: still muscle aches, with one event of vomiting and chills in the morning. No fever.
Pt came in to the pharmacy and told us that she had swollen eyes, lips and throat. Pt's other members of the family who got the shot on the same day did not have any reaction. When called next day to follow up pt said she feels better.
Headache; neck pain; photophobia; swelling; necrosis at site; fever 101.4 - x1 week.
Patient reported numbness and pain at injection site that radiated down arm. Patient was advised to take an NSAID per her primary care physician.
Fever, chills, h/a, swelling of rt side of face & lip, small area of erythema @ inject site, rash or hives;
Usually does not have the headaches that bad and can't get rid of them; has never had one like this before; can't have light on or anything; Tiredness; This is a spontaneous report from a contactable consumer (patient herself). A 26-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number, Expiry date, NDC number was not reported), via an unspecified route of administration, administered in Arm Right-top on 27Jul2021 at 12-1pm (Age at vaccination 26-years-old) as dose 1, single for covid-19 immunisation (clinic). The patient medical history and concomitant medications were not reported. Prior Vaccinations, the patient had not received any other vaccine within 4 weeks. Caller thought she had side effects to the Pfizer Covid vaccine and had headaches and tiredness. Usually does not have the headaches that bad and she can't get rid of them. Got the first vaccine on Tuesday, 27Jul2021. The headaches started a few days ago, probably on 06Aug2021 and she never had one like this before. They are the same that come, but she can't have light on or anything reported on 06Aug2021. The tiredness started about the 6th or 7th of August (Aug2021) and had gotten worse over the last 2 days. No further details provided. Unable to provide the , Lot, or expiry for the first dose. Vaccine card is in the car. No problems with vaccines in past. Knows there is nothing she can do about the side effects and just wanted to report this. Wants to know if it's okay to get the second vaccine with the side effects she is having. Recommended caller to seek medical provider for further medical advice. No further details provided. The outcome of events was not recovered.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
This may be purely coincidence, but the reaction was so severe, I thought you should have the puzzle piece.  On March 23 I donated blood.  Within 30 minutes I had a fever of 100.9, was extremely weak and sleepy, had the worst sore throat and radiating down in my memory.  It was difficult to even speak.  I have donated blood in decades and never had an adverse event.
symptoms of a mild heart attack; blood clot; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP) from a sales representative.  A 48 year-old male patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Comirnaty (DOSE 1), for covid-19 immunisation. The following information was reported: MYOCARDIAL INFARCTION (medically significant) with onset Dec2021, outcome "unknown", described as "symptoms of a mild heart attack"; THROMBOSIS (medically significant) with onset Dec2021, outcome "unknown", described as "blood clot". Approximately two months before the report, the patient with no history of heart disease, experienced symptoms of a mild heart attack; after being cathed, there was no sign of blockage, and it was determined to be a blood clot. Patient on blood thinners post occurrence. The patient underwent the following laboratory tests and procedures: cathed: no sign of blockage. Therapeutic measures were taken as a result of myocardial infarction, thrombosis. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Within 2 hours after immunizations, developed "big red lump" left upper arm, just to the side of the immunization site for DTaP. Area was "very hard, very sore, hot to touch."  Lump 2 1/2 " in diameter.  Next morning temperature was 102.8 axillary.  Lowest temperature that day was 100.8 ax.  Motrin given according to "regular schedule."  Ice applied to site.  2 days later (today - December 6th), mom states she does not think child has a fever.  Left upper arm still very sore, very hot, very hard. The rest of the arm is not swollen.  Mom states she will not have any more DTaP given to the child.
he now has a round purple mark on his hand; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 07Feb2022 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SKIN DISCOLOURATION (non-serious) with onset Feb2022, outcome "unknown", described as "he now has a round purple mark on his hand".  Additional Information: Patient received a Pfizer BioNTech covid 19 vaccines yesterday and he now has a round purple mark on his hand.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Systemic: Allergic: Anaphylaxis-Severe, Systemic: Allergic: Difficulty Breathing-Severe
Narrative:  1st Moderna vaccine: 2/16/2021 2nd moderna vaccine: 3/16/2021 covid positive: 1/26/2022 patient with current hospital say 1/26/2022 to present
Bad Headache, lasting 6 hours or longer.  Took 2 pills Equate Acetaminophen 500mg at time of onset and helped ease some but did not take it away.  Went to bed early and woke up next morning fine.  no more headache.
Approximately 6 months after my Covid 19 booster I have developed hot flashes and night sweats. I had gone through menopause and was hot flash free for several years prior to the Covid vaccines
Pt. woke up not feeling well, mom states that pt had chills and fever >102 degrees, body aches. Mom wanted pt check out in the Emergency Department. Pt did not have fever but was pale and complained of chills. ED doctor could not find a relationship with the vaccine but the pt. mother insisted on getting him checked out.
Patient reports increased SOB s/p 2nd dose of vaccination.  Symptoms began 1 week following 2nd dose. Continues to use home O2 therapy for improvement of symptoms. Advised to follow-up with PCP and Pulmonologist.
Mother reports redness and inflamation of the entire L upper arm. Pt reports difficulty using the arm due to pain. Vaccine administered in L deltoid.
In area of injection on right deltoid, warm to touch, red and swollen. Referred to PMD.
Patient reported having headaches on the same day after the vaccine was given.  The next day she noticed pain, redness, and swelling of the right arm (where the vaccine was given).  On the following day, she went to see her doctor, who prescribed a pain medication (Tramadol), and using an antihistamine and an ice pack.
lip numbness, and hand numbness Body achiness and head ache  raised swelling at injection sight 12 days after injection (raised, hot, and itchy).